These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28129069)
61. Relationship Between Exposure to Direct-To-Consumer Prescription Drug Advertising (DTCA) and Patients' Belief Accessibility and Medication Adherence. Im H; Huh J Health Commun; 2019 Aug; 34(9):975-983. PubMed ID: 29521524 [TBL] [Abstract][Full Text] [Related]
62. Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey. Aikin KJ; Sullivan HW; Berktold J; Stein KL; Hoverman VJ Health Mark Q; 2021; 38(1):1-11. PubMed ID: 34238134 [TBL] [Abstract][Full Text] [Related]
63. The Effect of Inconsistency Appeals on the Influence of Direct-to-Consumer Prescription Drug Advertisements: An Application of Goal Disruption Theory. Rosenberg BD; Siegel JT J Health Commun; 2016; 21(2):217-27. PubMed ID: 26716683 [TBL] [Abstract][Full Text] [Related]
64. Consumers responses to coupons in direct-to-consumer advertising of prescription drugs. Bhutada NS; Cook CL; Perri M Health Mark Q; 2009; 26(4):333-46. PubMed ID: 19916098 [TBL] [Abstract][Full Text] [Related]
65. Primary care physicians' use of FDA-approved prescription drug labels. Sullivan HW; O'Donoghue AC; Aikin KJ J Am Board Fam Med; 2014; 27(5):694-8. PubMed ID: 25201939 [TBL] [Abstract][Full Text] [Related]
66. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement. Lemanski JL; Villegas J Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298 [TBL] [Abstract][Full Text] [Related]
67. Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Southwell BG; Rupert DJ Int J Health Policy Manag; 2016 Jan; 5(3):211-3. PubMed ID: 26927597 [TBL] [Abstract][Full Text] [Related]
68. Disease-specific direct-to-consumer advertising for reminding consumers to take medications. Bhutada NS; Rollins BL J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486 [TBL] [Abstract][Full Text] [Related]
69. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea. Suh HS; Lee D; Kim SY; Chee DH; Kang HY Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104 [TBL] [Abstract][Full Text] [Related]
70. Variables associated with seeking information from doctors and the internet after exposure to direct-to-consumer advertisements for prescription medications. Fogel J; Teichman C Health Mark Q; 2014; 31(2):150-66. PubMed ID: 24878404 [TBL] [Abstract][Full Text] [Related]
71. Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements. O'Donoghue AC; Sullivan HW; Aikin KJ; Betts KR Ther Innov Regul Sci; 2014 May; 48(3):305-307. PubMed ID: 30235532 [TBL] [Abstract][Full Text] [Related]
72. Sources of traffic and visitors' preferences regarding online public reports of quality: web analytics and online survey results. Bardach NS; Hibbard JH; Greaves F; Dudley RA J Med Internet Res; 2015 May; 17(5):e102. PubMed ID: 25934100 [TBL] [Abstract][Full Text] [Related]
73. Readability of consumer health information on the internet: a comparison of U.S. government-funded and commercially funded websites. Risoldi Cochrane Z; Gregory P; Wilson A J Health Commun; 2012; 17(9):1003-10. PubMed ID: 22512714 [TBL] [Abstract][Full Text] [Related]
74. Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs. O'Donoghue AC; Sullivan HW; Aikin KJ Ann Behav Med; 2014 Dec; 48(3):311-22. PubMed ID: 24682975 [TBL] [Abstract][Full Text] [Related]
75. Experimental Study of the Promotional Implications of Proprietary Prescription Drug Names. Peinado S; O'Donoghue AC; Betts KR; Paquin RS; Giombi K; Arnold JE; Kelly BJ; Davis C Ther Innov Regul Sci; 2024 Sep; ():. PubMed ID: 39341979 [TBL] [Abstract][Full Text] [Related]
76. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Mackey TK Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871 [TBL] [Abstract][Full Text] [Related]
77. Direct to consumer advertising via the Internet, a study of hip resurfacing. Ogunwale B; Clarke J; Young D; Mohammed A; Patil S; Meek RM Scott Med J; 2009 Feb; 54(1):10-3. PubMed ID: 19291928 [TBL] [Abstract][Full Text] [Related]
78. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements. Wogalter MS; Shaver EF; Kalsher MJ Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979 [TBL] [Abstract][Full Text] [Related]
79. Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis. Sullivan HW; Aikin KJ; Poehlman J Health Commun; 2019 Feb; 34(2):212-219. PubMed ID: 29125325 [TBL] [Abstract][Full Text] [Related]
80. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising. West SL; Squiers LB; McCormack L; Southwell BG; Brouwer ES; Ashok M; Lux L; Boudewyns V; O'Donoghue A; Sullivan HW Pharmacoepidemiol Drug Saf; 2013 May; 22(5):447-58. PubMed ID: 23440924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]